About 1 result found for searched term "Bamlanivimab" (0.131 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M25152 | Bamlanivimab | Anti-infection |
| Anti-Human SARS-CoV-2 | ||
| Bamlanivimab (Anti-Human SARS-CoV-2) is the first COVID-19 monoclonal antibody (mAb) to be granted Emergency Use Authorization (EUA) in November 2020 by the U.S. Food and Drug Administration (FDA). However, Bamlanivimab is withdrawn in April 2021 following the rise of SARS-CoV-2 virus variants resistant to Bamlanivimab. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
